How we collaborate
Data stays at the hospital; only de-identified cases move
Every hospital collaboration follows the same pattern: retrospective, de-identified cases are shared under a data-use agreement, existing H&E slides are digitized locally or at a contracted facility, and predictions are benchmarked against the hospital's own NGS results.
No hospital is asked to change its existing pathology or sequencing workflow to participate in Phase 1.
Clinical collaborators
--Clinical collaboration
--Clinical validation partner
Technology & research partners
Causal ITResearch & AI collaboration
SRMIST BioNESTIncubation partner
Why partner with DocLane
What each type of partner gets
Hospitals
Early access to AI-assisted mutation insight research, with no change required to existing pathology workflows.
Research institutes
Co-authorship opportunities on validation findings and access to de-identified benchmarking results.